House Drug-Pricing Draft Bill A Departure From Gov’t Price Negotiation

Editor’s note: This story has been updated with a White House statement that staff-level talks on Medicare price negotiation continue with House Speaker Nancy Pelosi’s office. In a quick turn of events, the focus of drug-pricing legislation in the House shifted from Medicare negotiation to Part D reinsurance reform, which also is the approach that is being considered in the Senate . The House Energy & Commerce and Ways & Means committees released Thursday (May 23) a draft, bipartisan...